TABLE 2.
The average baseline and maximum arteriolar diameter for experiments testing the effect of purinergic membrane receptor inhibitor SUR on the conducted response elicited by muscle contraction. ‘n’ represents the number of 4A arterioles observed.
| Figure | Protocol | Baseline diameter (μm) | Maximum diameter (μm) | n |
|---|---|---|---|---|
| 2B | 6CPM(20 Hz) | 6.8 ± 2.0 | 14.6 ± 0.9 | 8 |
| 2B | 6CPM(20 Hz) + SUR | 5.4 ± 1.4* | ||
| 3B | 60CPM(20 Hz) | 5.8 ± 1.5 | ||
| 3B | 60CPM(20 Hz) + SUR | 6.1 ± 1.2 | ||
| 4B | 4 Hz(15CPM) | 9.0 ± 3.0 | 14.9 ± 2.5 | 13 |
| 4B | 4 Hz(15CPM) + SUR | 8.1 ± 3.0 | ||
| 5B | 40 Hz(15CPM) | 7.5 ± 2.8 | 14.9 ± 2.4 | 12 |
| 5B | 40 Hz(15CPM) + SUR | 7.8 ± 2.3 |
Note: Values are mean ± SD.
*
Baseline Significantly differed from stimulation parameter without drug.